Everand Logo

Welcome to Everand!

  • Discover this podcast and so much more

    Podcasts are free to enjoy without a subscription. We also offer ebooks, audiobooks, and so much more for just $11.99/month.

    Cytovia Therapeutics CEO Discusses SPAC Deal With Isleworth Healthcare

    Cytovia Therapeutics CEO Discusses SPAC Deal With Isleworth Healthcare

    FromSchwab Network

    Start listeningView podcast show

    Cytovia Therapeutics CEO Discusses SPAC Deal With Isleworth Healthcare

    FromSchwab Network

    ratings:
    Length:
    5 minutes
    Released:
    Apr 28, 2022
    Format:
    Podcast episode

    Description

    The CEO of Cytovia Therapeutics Dr. Daniel Teper joins The Watchlist to discuss the company's focus on building a next-generation immuno-oncology therapeutics platform. The company was founded in 2018, and develops NK-cell and NK-engager antibody platforms to improve tumor-specific targeting in oncology patients. Dr. Teper also highlights the company's SPAC merger with Isleworth Healthcare.
    Released:
    Apr 28, 2022
    Format:
    Podcast episode

    Titles in the series (100)

    A unique lineup of financial news and education programs, all available to stream without a subscription. Listen to industry experts track market action and interpret how it may apply to your investment portfolio. Get real-time insights, commentary, and exclusive access to CEOs, analysts, and market experts. Empowering Every Investor and Trader. Every Market Day. Produced by TD Ameritrade Media Productions Company, a wholly-owned subsidiary of TD Ameritrade Holding Corporation. TD Ameritrade Holding Corporation is a wholly owned subsidiary of The Charles Schwab Corporation. TD Ameritrade Media Productions Company is not a financial adviser, registered investment advisor, or broker-dealer. THE TD AMERITRADE NETWORK SITE, CONTENT, APPS, AND RELATED SERVICES, ARE PROVIDED ON AN “AS IS” AND “AS AVAILABLE” BASIS, WITHOUT WARRANTIES OF ANY KIND, EITHER EXPRESS OR IMPLIED. This is not an offer or solicitation in any jurisdiction where we are not authorized to do business or where such offer or solicitation would be contrary to the local laws and regulations of that jurisdiction, including, but not limited to persons residing in Australia, Canada, Japan, Saudi Arabia, UK, and the countries of the European Union. All TD Ameritrade Network content © TD Ameritrade Network. All rights reserved.